Novel Micro-Nanoprobes and Detection Method for Biomedical Applications

Award Information
Agency: Department of Energy
Branch: N/A
Contract: DE-FG02-04ER84009
Agency Tracking Number: 75586S04-I
Amount: $97,496.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: 23
Solicitation Number: DOE/SC-0075
Small Business Information
9140 Guilford Road, Suite O, Columbia, MD, 21046
HUBZone Owned: Y
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Henryk Szmacinski
 (301) 725-2775
Business Contact
 Wayne Moore
Title: Dr.
Phone: (301) 725-2775
Research Institution
75586-The development and wide application of fluorescence-based technology to the detection and monitoring of biomolecule interactions is limited by the signal produced by the probe, the size of the biomolecules, and the detection technology. Highly desired real-time detection, without washing steps, is currently limited to the methods of fluorescence polarization and surface plasmon resonance. There is need for detection techniques that have general application and provide high sensitivity without limitations to the size of the interacting biomolecules. This project will determine feasibility of combining Metal Enhanced Fluorescence (MEF) technology, spatially localized biomolecule interactions, and a PM (phase-modulation) technique in a substantially improved detection system. Phase I will fabricate micro-nanostructures and perform comparative studies (using standard fluorescent probes, a model protein system, and phase-modulation techniques) to prove that the new detection system is superior to the existing fluorescence polarization method for the detection of interacting biological molecules. Phase II will develop a reagent protocol and a prototype detection device. The new system will be complimentary to the well-established fluorescence polarization method. Commercial Applications and Other Benefits as described by the awardee: A system for the identification and detection of biomolecule interactions should have application to drug discovery, genomics, proteomics, and clinical diagnostics. The system should be substantially more general than fluorescence polarization (FP) and surface plasmon resonance (SPR) detection systems, which already are widely accepted and used in drug discovery research and in immunochemistry.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government